Marshall Wace North America’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Marshall Wace North America’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5,975	Closed	-$1.18M	–	1307
2020 Q2	$1.18M	Buy	+5,975	New	+$1.24M	0.01%	721
2019 Q4	–	Sell	-1,693	Closed	-$259K	–	1393
2019 Q3	$259K	Buy	+1,693	New	+$277K	﹤0.01%	913
2019 Q2	–	Sell	-18,751	Closed	-$2.21M	–	1310
2019 Q1	$2.21M	Buy	18,751 +11,233	+149%	+$1.13M	0.02%	480
2018 Q4	$691K	Sell	7,518 -16,476	-69%	-$1.67M	0.01%	701
2018 Q3	$2.7M	Buy	23,994 +17,294	+258%	+$1.83M	0.02%	433
2018 Q2	$618K	Buy	+6,700	New	+$650K	﹤0.01%	1035
2017 Q3	–	Sell	-17,011	Closed	-$1.31M	–	1354
2017 Q2	$1.31M	Buy	17,011 +5,514	+48%	+$464K	0.01%	851
2017 Q1	$989K	Buy	+11,497	New	+$828K	0.01%	703

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Marshall Wace North America's LKFT Position: Q3 2020 in Review

Marshall Wace North America sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2020, closing a stake of 5,975 shares — an estimated $1.18M sold.

Marshall Wace North America first reported a position in LKFT in Q1 2017 and held it in 8 quarters. The position peaked at $2.7M in Q3 2018. 119 funds tracked by Wall St. Rank hold LKFT as of Q3 2020.

Marshall Wace North America reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2020 after selling out during the quarter.
Marshall Wace North America sold 5,975 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2020, an estimated $1.18M.
Marshall Wace North America first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2017 and held it in 8 quarters.
Marshall Wace North America's Lakefront Biotherapeutics American Depositary Shares position peaked at $2.7M in Q3 2018.
119 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2020.

Based on Marshall Wace North America's 13F filing for Q3 2020, filed 16 Nov 2020.